Literature DB >> 21920157

Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting.

E Hurley1, A Coutsoudis, J Giddy, S E Knight, E Loots, T M Esterhuizen.   

Abstract

BACKGROUND: Obesity and undernutrition are common in South Africa and influence the health outcomes of people living with the human immunodeficiency virus (PLHIV). AIM: To describe the anthropometric changes and perceptions of body weight in adults initiated on antiretroviral therapy (ART).
METHODS: A cohort of 230 PLHIV was enrolled at an HIV clinic in Durban. Changes in their body mass index, and waist and hip girth were measured 6-monthly in the 12 months following initiation of ART. Data on demographic and socio-economic variables, CD4 counts, opportunistic infections and drug regimens used were recorded. Perceptions of body weight and desire to change these were ascertained.
RESULTS: Weight perceptions of respondents were incongruent with their body mass index, with the trend being to judge themselves as weighing less than their actual weight. Those wanting to gain weight gained an average of 7.8 kg - 2.8 times more than those satisfied with their weight (p<0.001). After 12 months on ART, there was a statistically significant increase in anthropometric measurements (p<0.001) with 43 of the 110 women having waist circumferences that increased their risk of cardiovascular disease; the incidence of lipodystrophy was 35% (62/177) (95% confidence interval 27-42%), 36% (64/177) were overweight and 22% (39/177) were obese, compared with 21% (49.230) and 12% (28/230) respectively at baseline (p=0.002).
CONCLUSION: There is a strong association between PLHIV's perception of body weight, their desire to gain weight and their actual weight gain on ART. Lipodystrophy, weight gain and truncal obesity are common among PLHIV after initiating ART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920157

Source DB:  PubMed          Journal:  S Afr Med J


  17 in total

1.  Association of Gut Intestinal Integrity and Inflammation with Insulin Resistance in Adults Living with HIV in Uganda.

Authors:  Michael J A Reid; Yifei Ma; Iya Golovaty; Samson Okello; Ruth Sentongo; Maggie Feng; Alexander C Tsai; Bernard Kakuhikire; Russell Tracy; Peter W Hunt; Mark Siedner; Phyllis C Tien
Journal:  AIDS Patient Care STDS       Date:  2019-06-12       Impact factor: 5.078

2.  Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.

Authors:  Alana T Brennan; Kaitlyn M Berry; Sydney Rosen; Andrew Stokes; Nigel J Crowther; Jaya George; Frederick Raal; Naseem Cassim; Ian Sanne; Lawrence Long; Matthew P Fox
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177

3.  Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings.

Authors:  Diana Huisin ʼt Veld; Eric Balestre; Jozefien Buyze; Joris Menten; Antoine Jaquet; David A Cooper; Francois Dabis; Constantin T Yiannoutsos; Lameck Diero; Portia Mutevedzi; Matthew P Fox; Eugene Messou; Christopher J Hoffmann; Hans W Prozesky; Matthias Egger; Jennifer J Hemingway-Foday; Robert Colebunders
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

4.  Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

Authors:  Vidya Mave; Kristine M Erlandson; Nikhil Gupte; Ashwin Balagopal; David M Asmuth; Thomas B Campbell; Laura Smeaton; Nagalingeswaran Kumarasamy; James Hakim; Breno Santos; Cynthia Riviere; Mina C Hosseinipour; Patcharaphan Sugandhavesa; Rosa Infante; Sandy Pillay; Sandra W Cardoso; Srikanth Tripathy; Noluthando Mwelase; Sima Berendes; Bruno B Andrade; David L Thomas; Robert C Bollinger; Amita Gupta
Journal:  J Infect Dis       Date:  2016-03-08       Impact factor: 5.226

5.  Distinct gender differences in anthropometric profiles of a peri-urban South African HIV population: a cross sectional study.

Authors:  Theodore A Nell; Maritza J Kruger; Dillan C Beukes; Esme Calitz; Rehana Essop; M Faadiel Essop
Journal:  BMC Infect Dis       Date:  2015-02-21       Impact factor: 3.090

6.  [Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo].

Authors:  Tshingani Koy; Henri Mukumbi; Ghislain Lubangi Muteba Malandala; Philippe Donnen; Michèle Wilmet-Dramaix
Journal:  Pan Afr Med J       Date:  2014-12-18

7.  Increasing Obesity in Treated Female HIV Patients from Sub-Saharan Africa: Potential Causes and Possible Targets for Intervention.

Authors:  Claire L McCormick; Arianne M Francis; Kim Iliffe; Helen Webb; Catherine J Douch; Mark Pakianathan; Derek C Macallan
Journal:  Front Immunol       Date:  2014-11-13       Impact factor: 7.561

8.  Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions.

Authors:  Gibson B Kagaruki; Mary T Mayige; Ester S Ngadaya; Godfather D Kimaro; Akili K Kalinga; Andrew M Kilale; Amos M Kahwa; Godlisten S Materu; Sayoki G Mfinanga
Journal:  BMC Public Health       Date:  2014-09-02       Impact factor: 3.295

9.  'If you have a problem with your heart, you have a problem with your life': Self-perception and behaviour in relation to the risk of ischaemic heart disease in people living with HIV.

Authors:  Ronel Roos; Hellen Myezwa; Helena van Aswegen
Journal:  Afr J Prim Health Care Fam Med       Date:  2015-03-31

10.  A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.

Authors:  Kristine M Erlandson; Sineenart Taejaroenkul; Laura Smeaton; Amita Gupta; Isaac L Singini; Javier R Lama; Rosie Mngqibisa; Cynthia Firnhaber; Sandra Wagner Cardoso; Cecilia Kanyama; Andre L Machado da Silva; James G Hakim; Nagalingeswaran Kumarasamy; Thomas B Campbell; Michael D Hughes
Journal:  Open Forum Infect Dis       Date:  2015-06-24       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.